首页> 美国卫生研究院文献>other >Microbial Carbonic Anhydrases in Biomimetic Carbon Sequestration for Mitigating Global Warming: Prospects and Perspectives
【2h】

Microbial Carbonic Anhydrases in Biomimetic Carbon Sequestration for Mitigating Global Warming: Prospects and Perspectives

机译:仿生碳固存中的微生物碳酸酐酶用于缓解全球变暖的前景和前景

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

All the leading cities in the world are slowly becoming inhospitable for human life with global warming playing havoc with the living conditions. Biomineralization of carbon dioxide using carbonic anhydrase (CA) is one of the most economical methods for mitigating global warming. The burning of fossil fuels results in the emission of large quantities of flue gas. The temperature of flue gas is quite high. Alkaline conditions are necessary for CaCO3 precipitation in the mineralization process. In order to use CAs for biomimetic carbon sequestration, thermo-alkali-stable CAs are, therefore, essential. CAs must be stable in the presence of various flue gas contaminants too. The extreme environments on earth harbor a variety of polyextremophilic microbes that are rich sources of thermo-alkali-stable CAs. CAs are the fastest among the known enzymes, which are of six basic types with no apparent sequence homology, thus represent an elegant example of convergent evolution. The current review focuses on the utility of thermo-alkali-stable CAs in biomineralization based strategies. A variety of roles that CAs play in various living organisms, the use of CA inhibitors as drug targets and strategies for overproduction of CAs to meet the demand are also briefly discussed.
机译:全球变暖严重破坏了人们的生活条件,世界上所有主要城市都对人类的生活逐渐变得荒凉。使用碳酸酐酶(CA)对二氧化碳进行生物矿化是缓解全球变暖的最经济方法之一。化石燃料的燃烧导致大量烟气的排放。烟气温度很高。碱性条件对于矿化过程中CaCO3的沉淀是必要的。因此,为了将CA用于仿生碳隔离,热碱稳定的CA是必不可少的。 CA也必须在存在各种烟气污染物的情况下保持稳定。地球上的极端环境中含有多种多极端微生物,它们是热碱稳定CA的丰富来源。 CA是已知酶中最快的,它是六种基本类型,没有明显的序列同源性,因此代表了趋同进化的一个很好的例子。当前的评论集中在热碱稳定的CA在基于生物矿化的策略中的实用性。还简要讨论了CA在各种活生物体中发挥的各种作用,使用CA抑制剂作为药物靶标以及为满足需求而过量生产CA的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号